Ignite Creation Date:
2024-05-05 @ 5:32 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00474045
Status:
COMPLETED
Last Update Posted:
2017-03-10
First Post:
2007-05-15
Brief Title:
Efficacy and Safety of Insulin Detemir Versus Neutral Protamine Hagedorn NPH Insulin in Pregnant Women With Type 1 Diabetes
Sponsor:
Novo Nordisk AS
Organization:
Novo Nordisk AS
Study Overview
Official Title:
A Randomised Parallel-group Open-labelled Multinational Trial Comparing the Efficacy and Safety of Insulin Detemir Levemir Versus Human Insulin NPH Insulin Used in Combination With Insulin Aspart as Bolus Insulin in the Treatment of Pregnant Women With Type 1 Diabetes
Status:
COMPLETED
Status Verified Date:
2017-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This trial is conducted in Africa Europe North and South America and Oceania The aim of this trial is to compare the effect and safety on blood glucose control in pregnant women with type 1 diabetes of a modern insulin analogue insulin detemir and human insulin NPH insulin given as long-acting insulin in combination with a short-acting insulin insulin aspart
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2006-004861-33 | EUDRACT_NUMBER | None | None |